| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Revenue | $55.3M | +132.3% |
| R&D Expense | $483.0M | +104.1% |
| SG&A Expense | $775.0M | +198.2% |
| Operating Income | -$1.35B | -26.2% |
| Interest Expense | $7.0M | +150.7% |
| Pre-tax Income | -$923.7M | -2.8% |
| Income Tax | $369K | -78.1% |
| Net Income | -$845.3M | -4.5% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.06B | +0.3% |
| Current Assets | $2.15B | -1.9% |
| Total Assets | $2.59B | -0.2% |
| Current Liabilities | $184.4M | -15.8% |
| Long-term Debt | $210.0M | +23.3% |
| Total Liabilities | $523.7M | -0.8% |
| Stockholders' Equity | $1.66B | -7.8% |
| Line Item | 2022-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$677.7M | -22.7% |
| Capital Expenditures | $17.4M | +200.3% |
| Investing Cash Flow | $303.3M | +1056.7% |
| Financing Cash Flow | $306.8M | -32.8% |
| Free Cash Flow | -$695.2M | -24.6% |